US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

44.660
+0.150+0.34%

Trading Feb 26 09:40 ET

3.83BMarket Cap-10.29P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 11, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	7.29M	35.69M	+28.40M
Beat Est.	-96.38%	-82.26%	+389.72%
EPS	-1.12	-0.44	+0.68
Beat Est.	-202.08%	-138.94%	+60.82%

Analyst Rating

Buy

Feb 26, 2025

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 9.758M	--
--	2025/Q1	-- / 6.777M	--
Feb 11, 2025	2024/Q4	35.691M / 7.288M	--
--	2024/Q3	602.000K / 7.132M	--
--	2024/Q2	517.000K / 13.613M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 9.758M--

--2025/Q1-- / 6.777M--

Feb 11, 20252024/Q435.691M / 7.288M--

--2024/Q3602.000K / 7.132M--

--2024/Q2517.000K / 13.613M--

Unlock Free Earnings Estimates

Open Account

CRISPR Therapeutics Earnings Reports

CRISPR Therapeutics | 10-K: FY2024 Annual Report

Feb 11 16:14 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 11 16:07 ET

CRISPR Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 09:16 ET

CRISPR Therapeutics | 8-K: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024 09:06 ET

Trending Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Feb 26, 2025

Buy

Buy
63.16%
Hold
31.58%
Sell
5.26%

Price Target

No Data